Yewei Liu
Overview
Explore the profile of Yewei Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liu Y, Lehar A, Rydzik R, Chandok H, Lee Y, Youngstrom D, et al.
Proc Natl Acad Sci U S A
. 2021 Aug;
118(33).
PMID: 34385332
Skeletal muscle and bone homeostasis are regulated by members of the myostatin/GDF-11/activin branch of the transforming growth factor-β superfamily, which share many regulatory components, including inhibitory extracellular binding proteins and...
12.
Du L, Zhang G, Yang D, Luo J, Liu Y, Zhang W, et al.
R Soc Open Sci
. 2021 Feb;
8(1):201480.
PMID: 33614083
In this work, a novel amphoteric copolymer named Poly(sodium p-styrenesulfonate--acrylic acid--diallyldimethylammonium chloride) (P(SS--AA--DMDAAC)) was synthesized via free radical polymerization. Afterwards, P(SS--AA--DMDAAC) was explored for use as a dispersant in coal...
13.
Wang H, Li Y, Liu J, Di D, Liu Y, Wei J
Food Sci Nutr
. 2020 Dec;
8(12):6528-6538.
PMID: 33312537
In the present work, we investigated the effect of L. polysaccharides (LBPs) on L-02 cells exposed to alcohol exploring the potential molecular mechanisms. Our results suggested that LBPs significantly prevented...
14.
Lee S, Lehar A, Liu Y, Ly C, Pham Q, Michaud M, et al.
Proc Natl Acad Sci U S A
. 2020 Nov;
117(49):30907-30917.
PMID: 33219121
Myostatin (MSTN) is a transforming growth factor-β (TGF-β) family member that normally acts to limit muscle growth. The function of MSTN is partially redundant with that of another TGF-β family...
15.
He J, Liu C, Li T, Liu Y, Wang S, Zhang J, et al.
Int J Med Sci
. 2020 Sep;
17(15):2269-2275.
PMID: 32922191
Cancer vasculature is immature, disorganized and hyperpermeable and can serve as a target for anti-cancer therapies. Vascular disrupting agents (VDAs) are tubulin protein binding and depolymerizing agents that induce rapid...
16.
Lee S, Lehar A, Meir J, Koch C, Morgan A, Warren L, et al.
Proc Natl Acad Sci U S A
. 2020 Sep;
117(38):23942-23951.
PMID: 32900939
Among the physiological consequences of extended spaceflight are loss of skeletal muscle and bone mass. One signaling pathway that plays an important role in maintaining muscle and bone homeostasis is...
17.
Wei J, Zhang L, Liu J, Pei D, Wang N, Wang H, et al.
J Food Biochem
. 2020 Aug;
44(10):e13412.
PMID: 32744344
The purpose of this research is to study the effect of Lycium barbarum polysaccharide on ethanol-induced liver injury and its mechanism. The cell survival rate, the apoptosis rate, and the...
18.
Liu Y, Wang S, Zhao X, Feng Y, Bormans G, Swinnen J, et al.
Diagnostics (Basel)
. 2020 Feb;
10(2).
PMID: 32024029
Vascular disrupting agents (VDAs) have entered clinical trials for over 15 years. As the leading VDA, combretastatin A4 phosphate (CA4P) has been evaluated in combination with chemotherapy and molecular targeting...
19.
Liu Y, Guan Q, Kong X, De Keyzer F, Feng Y, Chen F, et al.
Transl Oncol
. 2019 Dec;
13(1):92-101.
PMID: 31810003
To evaluate hepatobiliary-specific contrast agent (CA) mangafodipir trisodium (Mn-DPDP)-enhanced magnetic resonance imaging (MRI) for predicting the therapeutic efficacy of the vascular disrupting agent combretastatin A4 phosphate (CA4P) in rats with...
20.
Wang S, Liu Y, Feng Y, Zhang J, Swinnen J, Li Y, et al.
Cancers (Basel)
. 2019 Nov;
11(11).
PMID: 31766180
Cancer remains a major cause of death globally. Given its relapsing and fatal features, curing cancer seems to be something hardly possible for the majority of patients. In view of...